• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Factors associated with anticoagulation prescription in elderly patients with atrial fibrillation.

作者信息

Giorgi-Pierfranceschi Matteo, Artom Nathan, Di Pasquale Giuseppe, Squizzato Alessandro, Pellegrinet Marco, Romano Giulia, Tana Marco, Mathieu Giovanni, Maggioni Aldo Pietro, Fontanella Andrea, Campanini Mauro, Mazzone Antonino, Gussoni Gualberto, Dentali Francesco

机构信息

1 Department of Internal Medicine, Istituti Ospitalieri di Cremona, Italy.

2 Department of Internal Medicine, Ospedale S. Paolo di Savona, Italy.

出版信息

Eur J Prev Cardiol. 2019 Apr;26(6):660-663. doi: 10.1177/2047487318795237. Epub 2018 Aug 28.

DOI:10.1177/2047487318795237
PMID:30152250
Abstract
摘要

相似文献

1
Factors associated with anticoagulation prescription in elderly patients with atrial fibrillation.老年房颤患者抗凝处方的相关因素
Eur J Prev Cardiol. 2019 Apr;26(6):660-663. doi: 10.1177/2047487318795237. Epub 2018 Aug 28.
2
Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.直接口服抗凝剂和华法林治疗心房颤动患者的处方模式和结局：真实世界分析。
J Cardiovasc Pharmacol Ther. 2019 Sep;24(5):428-434. doi: 10.1177/1074248419841634. Epub 2019 Apr 29.
3
Use of oral anticoagulation therapy in the first 3 months after the diagnosis of atrial fibrillation in Israel: A population-based study.以色列诊断为心房颤动后 3 个月内口服抗凝治疗的使用情况：一项基于人群的研究。
J Cardiovasc Electrophysiol. 2020 Jun;31(6):1356-1363. doi: 10.1111/jce.14452. Epub 2020 Apr 1.
4
Rates and Determinants for the Use of Anticoagulation Treatment before Stroke in Patients with Known Atrial Fibrillation.已知心房颤动患者卒中前抗凝治疗的使用率及影响因素
Cerebrovasc Dis Extra. 2020;10(2):44-49. doi: 10.1159/000506923. Epub 2020 May 6.
5
Exploring the Quality of Anticoagulant Prescribed for Patients With Atrial Fibrillation at the St John of God Hawkesbury District Health Centre, New South Wales, Australia.探讨澳大利亚新南威尔士州圣约翰霍克斯伯里地区卫生中心为房颤患者开具的抗凝药物质量。
J Cardiovasc Pharmacol Ther. 2019 Jan;24(1):46-53. doi: 10.1177/1074248418786264. Epub 2018 Jul 1.
6
Trends in Atrial Fibrillation and Prescription of Oral Anticoagulants and Embolic Strokes in Germany.德国心房颤动、口服抗凝剂处方及栓塞性中风的趋势
Cardiovasc Revasc Med. 2019 May;20(5):399-402. doi: 10.1016/j.carrev.2018.07.019. Epub 2018 Jul 21.
7
Effectiveness and Safety of Direct Oral Anticoagulants in Relation to Temporal Changes in Their Use.直接口服抗凝剂使用的时间变化与其有效性和安全性的关系
Circ Cardiovasc Qual Outcomes. 2020 Mar;13(3):e005894. doi: 10.1161/CIRCOUTCOMES.119.005894. Epub 2020 Mar 12.
8
Evolving Changes of the Use of Oral Anticoagulants and Outcomes in Patients With Newly Diagnosed Atrial Fibrillation in Taiwan.台湾新诊断房颤患者口服抗凝药使用情况及结局的演变性变化
Circulation. 2018 Oct 2;138(14):1485-1487. doi: 10.1161/CIRCULATIONAHA.118.036046.
9
Underuse of Vitamin K Antagonist and Direct Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation: A Contemporary Review.维生素 K 拮抗剂和直接口服抗凝剂在预防心房颤动患者中风中的应用不足：当代综述。
Clin Pharmacol Ther. 2018 Aug;104(2):301-310. doi: 10.1002/cpt.1024. Epub 2018 Feb 13.
10
Provider Specialty, Anticoagulation Prescription Patterns, and Stroke Risk in Atrial Fibrillation.医疗机构类型、抗凝药物处方模式与房颤患者的卒中风险
J Am Heart Assoc. 2018 Mar 10;7(6):e007943. doi: 10.1161/JAHA.117.007943.

引用本文的文献

1
Clinical characteristics of apixaban prescription in AF patients with single dose-reduction criterion: the ASPIRE (efficAcy and safety of aPixaban in rEal-world practice in Korean frail patients with atrial fibrillation) study.采用单剂量减量标准的房颤患者阿哌沙班处方的临床特征：ASPIRE（阿哌沙班在韩国老年房颤患者真实世界实践中的有效性和安全性）研究
Front Cardiovasc Med. 2024 Jun 10;11:1367623. doi: 10.3389/fcvm.2024.1367623. eCollection 2024.